-
Hepatitis C human challenge studies and liver cancer risk
In a hepatitis C human challenge study, volunteers would be infected with the virus for several months before receiving free…
-
1Day Sooner poll shows bipartisan support for global vaccine assistance
1Day Sooner commissioned polling from Positive Sum Strategies to understand U.S. voters’ knowledge levels on malaria vaccines and public support…
-
Explaining 1Day Africa’s dose target
By Ollie Sayeed, PhD 1Day Africa is advocating for a target of distributing 200 million malaria vaccine doses by the…
-
Beyond the needle: Understanding the safety of life-saving malaria vaccines
Iain Macleod Briongos, PhD The RTS,S and R21 vaccines represent significant advances in the fight against malaria and are now…
-
10 country-specific insights from Africa’s fight against malaria
By Ollie Sayeed, PhD 1Day Sooner has compiled a tracker for each African country, collecting important information such as: the…
-
1Day Sooner hosts roundtable on human challenge studies during emerging health emergencies
Earlier this year, the WHO released draft guidelines on the ethics of using challenge studies during public health emergencies. Human…
-
How cost-effective is the new R21 vaccine compared to existing malaria interventions?
Karam Elabd and Ryan Duncombe, PhD Summary This post evaluates the cost-effectiveness of two malaria vaccines, RTS,S and R21, compared…
-
How are vaccines distributed through Gavi?
By Isla Gibson What is Gavi? Gavi was founded in 2000 as the Global Alliance for Vaccines and Immunization…
-
1Day Sooner issues letter to amend CA SB 1308
The California legislature’s proposed SB 1308 aims to reduce ozone and other volatile compounds found in the air. Here at…
-
What lessons can be learned from COVID-19 vaccine rollout in Africa?
By Iain Macleod Briongos, PhD The deployment of COVID-19 vaccines from 2020 onwards represented an unprecedented global effort, surpassing all…
-
How much will the R21 malaria vaccine save in medical costs of treating malaria?
By David Tellett Our estimates indicate that a full course of the R21/Matrix-M malaria vaccine can be delivered for around…
-
1Day Sooner’s Comments on SB-1308 and Effects on Germicidal UV Light Technology
By Gavriel Kleinwaks, the lead indoor air quality researcher at 1Day Sooner, a public health nonprofit that pursues campaigns in…
-
How many lives could be saved through malaria vaccination?
By David Tellett Children in many regions of Sub-Saharan Africa are regularly and repeatedly subjected to infection from the malaria…
-
How many malaria vaccine doses are needed in Africa?
By David Tellett Sub-Saharan Africa is home to over 1 billion people, and according to WHO estimates for 2021, approximately…
-
Understanding the immunology of the RTS,S and R21 malaria vaccines
By 1Day Sooner’s Ryan Duncombe, PhD. The following expands on information in 1Day Africa’s R21 Status Report. Even though phase 3…